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SUMMARY
Biofilms are structured communities of bacteria that
are held together by an extracellular matrix consist-
ing of protein and exopolysaccharide. Biofilms often
have a limited lifespan, disassembling as nutrients
become exhausted and waste products accumulate.
D-amino acids were previously identified as a self-
produced factor that mediates biofilm disassembly
by causing the release of the protein component
of the matrix in Bacillus subtilis. Here we report
that B. subtilis produces an additional biofilm-
disassembly factor, norspermidine. Dynamic light
scattering and scanning electron microscopy exper-
iments indicated that norspermidine interacts
directly and specifically with exopolysaccharide.
D-amino acids and norspermidine acted together to
break down existing biofilms and mutants blocked
in the production of both factors formed long-lived
biofilms. Norspermidine, but not closely related poly-
amines, prevented biofilm formation by B. subtilis,
Escherichia coli, and Staphylococcus aureus.
INTRODUCTION
Many bacteria form complex multicellular communities, known
as biofilms, on surfaces and interfaces (Bryers, 2008; O’Toole
et al., 2000). A hallmark of biofilms is an extracellular matrix typi-
cally consisting of protein, exopolysaccharide, and sometimes
DNA, that holds the cells together in the community. Biofilms
are of high significance in agricultural, industrial, environmental,
and clinical settings. For example, the soil bacterium Bacillus
subtilis protects plants from a variety of pathogens by forming
biofilms on the roots (Nago´rska et al., 2007). Biofilms are inher-
ently resistant to antimicrobial agents and are at the center of
many persistent and chronic bacterial infections (Costerton
et al., 1999). For example, biofilm formation plays a critical role
in many device-related infections, infective endocarditis, urinary
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as Staphylococcus aureus and Staphylococcus epidermidis
(Bryers, 2008; Otto, 2008). Biofilms have natural life cycles;
they form under propitious conditions, and they disassemble
as they age (Karatan and Watnick, 2009; Romero and Kolter,
2011).
Here we focus on the biofilm life cycle of B. subtilis, which
under laboratory conditions forms floating biofilms known as
pellicles at the air-liquid interface of standing cultures (Aguilar
et al., 2007; Branda et al., 2001a; Lopez et al., 2009; Vlamakis
et al., 2008). Cells in the pellicles are held together by an extra-
cellular matrix consisting of exopolysaccharide and amyloid-
like fibers largely composed of the protein TasA (Branda et al.,
2006a; Branda et al., 2004; Romero et al., 2010). B. subtilis bio-
films have a limited life span, maturing after 3 days of incubation
in biofilm-inducing medium at 22C but disassembling and
releasing individual planktonic cells by 8 days (Kolodkin-Gal
et al., 2010; Romero et al., 2011).
How do cells in the B. subtilis pellicle escape from the matrix
and return to a planktonic existence during biofilm disassembly?
We previously found that conditionedmedium from an 8-day-old
culture contains factors that prevent pellicle formation when
added to a fresh culture. One such factor is a mixture of the
D-amino acids D-Tyr, D-Leu, D-Trp, and D-Met. These amino
acids are incorporated into the cell wall peptidoglycan where
they trigger the release of the amyloid fibers from the cell
(Cava et al., 2011; Kolodkin-Gal et al., 2010; Romero et al.,
2011). Fiber release is mediated via an adaptor protein TapA,
which forms D-amino acid-sensitive foci in the cell wall and is
required for the formation of the fibers and their anchorage to
the cell wall (Romero et al., 2011). D-amino acids were also found
to inhibit biofilm formation by other bacteria, such as S. aureus
and Pseudomonas aeruginosa (Hochbaum et al., 2011; Kolod-
kin-Gal et al., 2010).
Here we report the discovery of a second biofilm-disassembly
factor present in conditioned medium from aging B. subtilis bio-
films. The factor is the polyamine norspermidine, and evidence
indicates that it directly interacts with the exopolysaccharide.
The effect was specific in that other closely related polyamines,
such as spermidine, had little biofilm-inhibiting activity. Mutants
CT
Figure 1. Identification of Norspermidine in Condi-
tioned Medium from B. subtilis and Its Effect on
Pellicle Formation
(A) Biofilm-inhibiting factors in conditioned medium.
B. subtilis strain NCBI3610 was grown at 22C in 12-well
plates in liquid biofilm-inducing medium for 3 or 8 days.
Conditioned medium (500 ml) from an 8-day-old culture
was concentrated on the C-18 column and eluted step-
wise with methanol. Shown is the result of growing cells in
fresh medium to which had been added 20 ml of the 25%,
35%, or 40% methanol eluates.
(B) Norspermidine inhibits biofilm formation. Cells of
NCBI3610 were grown in fresh medium containing PBS
buffer (control), norspermidine (100 mM), morpholine
(100 mM), HPLC-purified fatty acid (100 mM), or spermi-
dine (100 mM). Brighter images of the norspermidine-
treated cell revealed cells near the bottom of the well.
(C) Detection of norspermidine. Pellicles were collected
from 3- and 8-day-old cultures (100 ml) of the wild-type
(NCBI3610) and from an 8-day-old culture (100 ml) of a
gabT mutant (IKG623). After mild sonication of the pelli-
cles, cells were separated from extracellular material.
(Other experiments showed that norspermidine is largely
found in pellicles.) Norspermidine in the extracellular
material was derivatized with Fmoc-Cl, and the resulting
Fmoc-norspermidine was detected with an Agilent LC/MS
system. Fmoc-norspermidine was detectable in the old
pellicle from wild-type cells but not in the young or mutant
pellicles. See also Figure S1B.
(D and E) Quanitification of the biofilm-inhibiting activity of
norspermidine and spermidine. Pellicle formation of strain
NCBI3610 was tested in the presence of the indicated
concentrations of norspermidine (D) or spermidine (E). See
also Figure S1A.AC
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Dblocked in the production of both D-amino acids and norspermi-
dine formed long-lived pellicles, andD-amino acids and norsper-
midine acted together in breaking down existing, mature
pellicles. Thus, B. subtilis produces factors that act in a comple-
mentary manner to free cells from the protein and exopolysac-
charide components of the matrix. Finally, we report that
norspermidine was effective in inhibiting biofilm formation by
other bacteria, including S. aureus and Escherichia coli.
RESULTS
Norspermidine Is Self-Produced Biofilm-Inhibiting
Factor
Building on earlier work indicating that aging B. subtilis pellicles
produce two biofilm-inhibiting factors, we applied conditioned
medium to a C-18 Sep-Pak column and collected fractions by
using stepwise elution in 5% percent increments from 5%
to 40% methanol. The 25% and 40% eluates contained
compounds active in inhibiting biofilm formation, whereas the
35% eluate was inert (Figure 1A). As reported previously, the
factor in the 40% eluate was a mixture of D-amino acids (Kolod-
kin-Gal et al., 2010). To identify the second biofilm-inhibiting
factor, we carried out high-performance liquid chromatography
(HPLC) on the 25% methanol eluate by using a phenyl-hexyl
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TR column. Inhibitory activity was recovered with an elution time of40 min. Proton nucleic magnetic resonance (NMR) analysis ofthe active fraction revealed fatty acids, morpholine, and norsper-midine. Further purification with a C-18 HPLC column identifiedthe inhibitory agent as norspermidine, a finding confirmed with
authentic norspermidine, which inhibited biofilm formation at
25 mM (Figure 1B and Figure S1A, available online). Puremorpho-
line and fatty acids detected by NMR were inactive (Figure 1B).
Norspermidine’s tendency to form strong complexeswith fatty
acids, which explains its elution at 25% methanol from the C-18
Sep-Pak column, complicated its quantification. To circumvent
this problem, we treated conditioned medium with 9-fluorenyl-
methyloxycarbonyl chloride (Fmoc-Cl), which protects the amino
groups of norspermidine as carbamates and thereby prevents
their interaction with other molecules (Molna´r-Perl, 2003).
Fmoc-norspermidine was detected and quantified by liquid
chromotography/mass spectrometry (LC/MS) (Figure S1B).
Using this procedure, we found that norspermidine was present
at a concentration of 50–80 mM in 8-day-old, disassembling
pellicles but at a concentration of less than 1 mM in a 3-day-old
pellicle (Figure 1C).
Finally, the effect of norspermidine was specific in that a
closely related polyamine, spermidine, which differs from nor-
spermidine by the presence of an extra methylene group, wasCell 149, 684–692, April 27, 2012 ª2012 Elsevier Inc. 685
Figure 2. Norspermidine Acts Together with
D-amino Acids
(A) Pellicle longevity. Shown are 7-day-old cultures of the
wild-type (WT), a mutant (ΔgbaT) blocked in norspermi-
dine production (IKG623), a double mutant (ΔylmE ΔracX)
blocked in D-amino acid production (IKG55), and a triple
mutant (ΔgbaT ΔylmE ΔracX) blocked in the production of
both (IKG625). See also Figure S2A.
(B) Preventing biofilm formation. Cells were grown for
3 days in medium containing as indicated D-tyrosine
(D-Tyr), norspermidine, a mixture of D-tyrosine, D-methi-
onine, D-leucine, and D-tryptophan (D-aa) and the indi-
cated combinations of amino acids and norspermidine at
the indicated concentrations.
(C) Quantifying pellicle breakdown. On the surface of
3-day-old pellicles were placed droplets (50 ml) containing
buffer (PBS), a mixture of D-tyrosine, D-methionine,
D-leucine, and D-tryptophan each at final concentration of
12.5 mM, norspermidine at a final concentration of 50 mM,
or, as in (C), a combination of D-amino acids each at
a concentration of only 2.5 mM and norspermidine at a
concentration of 10 mM. After incubation for the indicated
times, pellicle material and the medium were separated
and each brought to a volume of 3 ml. After mild sonica-
tion, the OD600 was determined for each sample. The
percentage of disassembly represents the OD600 of
the medium as a percent of the sum of the OD600 of the
medium and the OD600 of the pellicle. The results are
an average of three independent experiments done in
duplicate. The error bars indicate standard deviation.CT
Einactive in inhibiting biofilm formation at concentrations up to
2 mM (Figures 1D and 1E).
A Mutant Blocked in Both D-Amino Acid and
Norspermidine Production Forms Long-Lived Biofilms
To evaluate the contribution of norspermidine to biofilm
disassembly genetically, we created a mutation blocking its
production. Norspermidine is synthesized from aspartate-
b-semialdehyde in a pathway involving the enzyme L-diamino-
butyric acid transaminase (Lee et al., 2009). We constructed
a mutant lacking the B. subtilis gene (gabT) encoding this
enzyme and found that themutant was blocked in norspermidine
production (Figure 1C) and was partially impaired in biofilm
disassembly (Figure 2A). The gabT mutant formed pellicles that
remained relatively thick at a time (day 7) when the wild-type
had undergone substantial disassembly. Nonetheless, the
mutant pellicle had lost the wrinkly phenotype characteristic of
young biofilms by day 7. We wondered whether the contribution
of norspermidine to biofilm disassembly might be partially
redundant with that of D-amino acids, which are produced by
racemases encoded by racX and ylmE. Like a gabT mutant,
a racX ylmE double mutant was partially impaired in biofilm
disassembly. Strikingly, however, a gabT racX ylmE triple mutant
formed robust pellicles that retained their wrinkly phenotype at
a time (7 days) when the wild-type had substantially disas-
sembled (Figure 2A). As a further test of the involvement of
norspermidine in biofilm disassembly, we constructed a mutant
lacking carboxynorspermidine decarboxylase, which catalyzes
the last step in the biosynthetic pathway. As in the case of the
gabT mutant, a mutant lacking the B. subtilis homolog (yaaO)
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disassembly, and a yaaO racX ylmE triple mutant formed
pellicles that remained intact at a time when the wild-type had
disassembled (Figure S2A).
D-Amino Acids and Norspermidine Act Together in
Preventing Biofilm Formation and Triggering Biofilm
Disassembly
These findings suggest that norspermidine and D-amino acids
act by different mechanisms to trigger biofilm disassembly.
Consistent with this idea, combinations of norspermidine with
D-Tyr or with a mixture of D-Met, D-Trp, D-Leu, and D-Tyr effec-
tively prevented biofilm formation at concentrations that were
ineffective in blocking biofilm formation when applied separately
(Figure 2B). Similarly, a mixture of D-amino acids and norspermi-
dine was more effective in causing the breakdown of an existing
biofilm than were either D-amino acids or norspermidine alone
(Figure 2C). Thus, D-amino acids and norspermidine act together
in preventing biofilm formation and triggering the disassembly of
mature biofilms.
Norspermidine Targets the Exopolysaccharide
How does norspermidine trigger biofilm disassembly? A clue
came from the observation that the residual pellicle (wispy frag-
ments of floating material with some structure) produced in the
presence of norspermidine resembled pellicles seen for amutant
blocked in exopolysaccharide production but not those (thin,
featureless pellicles) seen for a mutant blocked in amyloid-fiber
production. More importantly, norspermidine had little effect on
the residual pellicle produced by an exopolysaccharide mutant
Figure 3. Norspermidine Disrupts Exopolysac-
charide
Shown are phase contrast and fluorescence images of
cells of the wild-type (WT; NCBI3610) harvested from
pellicles grown in the presence or absence (untreated)
of norspermidine (25 mM) or a high concentration of
spermidine (1 mM). The cells were washed in PBS and
stained for exopolysaccharide with a conjugate of
concanavalin A with Texas red. See also Figure S2B and
Figure S3.
A
but abolished pellicle formation by the amyloid-fiber mutant.
In other words, the effect of norspermidine was synergistic
with that of a mutation blocking fiber formation but not with
a mutant blocked in exopolysaccharide production (Figure S2B).
These observations suggested that norspermidine was inter-
fering with the exopolysaccharide component of the matrix.
To investigate this hypothesis, we visualized exopolysacchar-
ide by fluorescence microscopy by using a conjugate of the
carbohydrate-binding protein concanavalin A with Texas red
(Figure 3) (McSwain et al., 2005). As evidence of specificity, the
conjugate decorated wild-type cells but not cells from a mutant
(Δeps) blocked in exopolysaccharide production (Figure S3A).
Indeed, at an exposure at which concanavalin A staining with
the wild-type strain gave an extremely bright fluorescent signal,
little or no signal could be detected for the Δeps mutant, except
at long exposures and enhanced brightness (Figure S3A). Next,
we investigated the effects of norspermidine and spermidine.
Figure 3 shows that norspermidine treatment disrupted the
relatively uniform, cell-associated pattern of staining seen with
untreated cells, resulting in isolated patches of fluorescence.
No such effect was seen with cells treated with spermidine.
Simply mixing norspermidine with concanavalin A did not
quench the intensity of fluorescence of the flurophore (data not
shown). Hence, the difference in the staining was evidently due
to differential levels of cell-associated exopolysaccharide. As
a control, and in contrast to the results seen with concanavalin
A, norspermidine had little or no effect on the protein component
of the matrix as judged with a functional fusion of TasA to the
fluorescent protein mCherry (Figure S3B) (Kolodkin-Gal et al.,
2010). We infer that norspermidine disrupts the matrix and
apparently does so by targeting exopolysaccharide.
Norspermidine but Not Spermidine Interacts
with Exopolysaccharide
The expression of the operons epsA-O and yqxM-sipW-tasA,
which specify the exopolysaccharide and protein components
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not measurably impaired by the addition of
norspermidine (Figure S4). Also, cell growth
was not significantly inhibited by norspermi-
dine (Figure S4). We therefore considered the
possibility that norspermidine was interacting
with the exopolysaccharide directly. To attempt
to detect such an interaction, we used dynamic
light scattering, a standard procedure for
measuring the average radius of polymersTE
D(Berne and Pecora, 1976; Orgad et al., 2011; Vinayahan et al.,
2010).
Figure 4A shows that purified exopolysaccharide exhibited
an average radius of 585 ± 40 nm at pH 5.5, presumably repre-
senting an effective radius for the interacting polymers. Strik-
ingly, treatment of the exopolysaccharide with norspermidine
reduced the average radius substantially (175 ± 10 nm), whereas
treatment with spermidine had only a small effect on the average
radius (500 ± 20 nm). This indicates that the specificity of nor-
spermidine resulted from a direct interaction with exopolysac-
charide. The effect of norspermidine was seen over a range of
exopolysaccharide concentrations (1–30 mg/ml) (Figure 4A and
data not shown) and also at pH 7 (Figure 4A).
As an independent approach to detecting an interaction
between norspermidine and exopolysaccharide, we carried out
scanning electron microscopy. Purified exopolysaccharide was
seen to be in the form of aggregates, which had an average
diameter of 570 nm (Figure 4B; data not shown). Strikingly,
the addition of norspermidine reduced the diameter of the
aggregates to 85 nm (Figure 4B; data not shown). Once again,
and, as a demonstration of specificity, spermidine had little
effect on the size of the aggregates.
Use of a Panel of Small Molecules Reveals Features
Important for Biofilm-Inhibitory Activity
To identify features of norspermidine important for its biofilm-
disassembly activity, we tested a library of polyamines in our
biofilm inhibition assay (see Figures 5A and 5B, Figure S5, and
Table S2). In addition to norspermidine (1), we found that
norspermine (2) exhibited biofilm-inhibitory activity against
B. subtilis. These molecules have in common a motif consisting
of three methylene groups flanked by two amino groups. The
motif is present twice in (1) and three times in (2). Another poly-
amine, 1,3-diaminopropane (6), has only one copy of the motif
and was significantly less active (>5 mM). Also relatively inactive
(inhibition was only observed at concentrations above 2 mM)
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Figure 4. Norspermidine Interacts with Exopoly-
saccharide Polymers
(A) Dynamic light scattering. Listed are the average
hydrodynamic radii of the exopolysaccharide as mea-
sured by dynamic light scattering. Exopolysaccharide was
purified from pellicles. Light scattering was measured for
exopolysaccharide alone as well as for exopolysaccharide
that had been mixed with 0.75 mM norspermidine or with
0.75mMspermidine. Shown are the results obtained in the
absence of polyamine (black) in the presence of nor-
spermidine (white) and in the presence of spermidine
(gray) with exopolysaccharide at the indicated concen-
trations and pH. Error bars represent the standard devia-
tion of polymer radii in a single sample.
(B) Scanning electron microscopy Purified exopoly-
saccharide was dissolved in DDW at a final concentration
of 10 mg/ml and mixed with either norspermidine or
spermidine (0.75 mM final concentration). Samples were
prepared as described in Experimental Procedures.
Shown are three different magnifications of representative
fields showing exopolysaccharide alone (EPS) and exo-
polysaccharide that had been mixed with norspermidine
(EPS + norspermidine) or with spermidine (EPS + sper-
midine). See Figure S4 for controls showing little effect on
growth or eps transcription.CT
Ewere spermidine (3), spermine (4), and putrescine (5), which
each have a pair of amines separated by four methylenes, and
cadaverine (19), which has a pair of amines separated by five
methylenes. Replacing some or all of the amines in norspermi-
dine with tertiary amines (7–9, 18), replacing the secondary
amine with an ether linkage (10) or eliminating two or all of the
amines (20, 11) resulted in molecules that were relatively inac-
tive. Whereas replacing the terminal amines with tertiary amines
resulted in inactivity, in one case (21) the presence of a tertiary
amine at the middle position did not block activity. Importantly,
the charge of each amine (at the neutral pH of the medium)
was also important for biofilm-inhibiting activity. Molecules that
had neutral amide bonds instead of amines separated by three
methylenes (15–17)were onlyweakly active or inactive (Figure S5
and Table S2).
We conclude that the structure and the charge of the poly-
amine are required for biofilm-inhibiting activity. In particular,
a motif consisting of three methylene groups flanked by two
positively charged amino groups is favored for high biofilm-in-
hibiting activity. Reinforcing this hypothesis, three additional,
synthetic polyamines exhibiting this motif (12, 13 and 14) were
active (Figure S5).
Norspermidine but Not Spermidine Inhibits Biofilm
Formation by S. aureus and E. coli
We wondered whether polyamines might prevent biofilm forma-
tion by other bacteria that produce an exopolysaccharidematrix.
Indeed, the same molecules that inhibited biofilm formation by
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formation (but not growth; data not shown)
by S. aureus and E. coli, whereas those that
were inactive with B. subtilis were not (Figures6 and 7 and Figure S6). In testing E. coli we chose the biofilm-
proficient strain MC4100 because a major component of exopo-
lysaccharide is colanic acid (Danese et al., 2000; Price and
Raivio, 2009). Colanic acid is a negatively charged polymer,
and light scattering experiments indicated a direct interaction
with norspermidine (data not shown). Reinforcing the idea that
norspermidine was targeting the exopolysaccharide, fluores-
cence microscopy experiments analogous to those presented
above for B. subtilis showed markedly diminished staining of
exopolysaccharide when cells of S. aureus and E. coli were
treated with norspermidine but not spermidine (data not shown).
Interestingly, and in contrast to the above results, norspermi-
dine is reported to promote rather than inhibit biofilm formation
by Vibrio cholerae (Lee et al., 2009). Evidence indicates that in
V. cholerae norspermidine acts to de-repress biofilm formation
via a signal transductionmechanism (Karatan et al., 2005). None-
theless, and despite the V. cholerae exception, our results
support the concept that biofilm formation can be prevented
and existing biofilms disrupted by molecules that interact
directly with exopolysaccharides.
DISCUSSION
B. subtilis forms architecturally complex biofilms (pellicles) at the
air/liquid interface of standing cultures (Aguilar et al., 2007;
Branda et al., 2001b). These floating communities are transient;
they mature after 3 days in biofilm-inducing medium but then
disassemble by 8 days, releasing individual planktonic bacteria
Figure 5. Structure Activity Relationship Study of Norspermidine
(A) Shows compounds tested for biofilm-inhibiting activity.
(B) Shows the effect of the numbered compounds on pellicle formation by B. subtilis (NCBI3610). The compounds were tested at 200 mM.
(C and D) show the results of modeling the interaction of norspermidine and spermidine with an acidic exopolysaccharide. Norspermidine binds via salt
bridges between amino and carboxyl groups (dotted lines) in a clamp-like mode across the exopolysaccharide secondary structure of a disaccharide repeat.
[a(1,6)Glc-b(1,3)GlcA]n. Whereas norspermidine aligns well with the repeat, the spacing of amino groups of spermidine does not match the symmetric pattern
of anionic side groups, implying weaker affinity. See supporting information for modeling of plausible interactions with other charged and non-charged
polysaccharide structures. For tests of additional molecules see Figure S5 and Table S2.AC
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D(Kolodkin-Gal et al., 2010). Cells in the biofilm are held together
by exopolysaccharide and amyloid-like fibers largely consisting
of TasA (Branda et al., 2006b; Branda et al., 2004; Romero et al.,
2010). The return of cells in the biofilm to a planktonic state must
therefore involve mechanisms for their release from the exopoly-
saccharide and protein components of the matrix. One such
mechanism is the production late in the life cycle of the D-amino
acids D-Tyr, D-Leu, D-Trp, and D-Met, which are incorporated
into the peptidoglycan where they trigger the release of the
TasA fibers (Kolodkin-Gal et al., 2010). This release is mediated
by an adaptor protein, TapA, which forms D-amino acid-sensi-
tive foci in the cell wall (Romero et al., 2011). Here we have
reported the discovery of a second biofilm-disassembly factor,
norspermidine, which is also produced late in the life cycle
of the biofilm and is required for complete disassembly of
B. subtilis biofilms. Importantly, mutants blocked in the produc-
tion of both D-amino acids and norspermidine formed long-lived
pellicles that retained their architectural complexity for extended
periods of time. We do not fully know the mechanism(s) by which
the production of norspermidine and D-amino acids is delayed
until late in the biofilm life cycle but experiments based on the
use of lacZ fused to genes involved in norspermidine (gabT
and yaaO) and D-amino acid biosynthesis (the racemase genes
racX and ylmE) indicate that regulation occurs at the level of
gene transcription (L. Silverstein, Y. Chai, I.K.-G., unpublished
results).
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TThe biofilm-inhibiting effect of norspermidine was specific in
that a closely related polyamine, spermidine (differing only by
an extra methylene group), exhibited little activity. Interestingly,
another polyamine, norspermine, was also active in biofilm inhibi-
tion, whereas its close relative spermine (once again having an
extra methylene) was inactive. These results and the results of
usingapanelof seventeenadditional compoundssuggest thatbi-
ofilm inhibition depends on amotif of two or three pairs of primary
or secondary charged amines separated by three methylenes.
Several lines of evidence indicate that norspermidine acts in
a complementary manner to D-amino acids by targeting the
exopolysaccharide. First, norspermidine and D-amino acids
acted cooperatively in inhibiting biofilm formation, suggesting
that they function by different mechanisms. Second, pellicles
formed in the presence of norspermidine resembled the wispy,
fragmented material produced by an exopolysaccharide mutant
but not the thin, flat, featureless pellicle of a mutant blocked
in amyloid-fiber production. Third, fluorescence microscopy
showed that norspermidine (but not spermidine) disrupted the
normal uniform pattern of staining of exopolysaccharide but
had little effect on the staining pattern of the protein component
of the matrix. Finally, and most directly, light scattering and
electron microscopy experiments revealed that norspermidine,
but not spermidine, interacted with purified exopolysaccharide.
Remarkably, the biofilm-inhibiting effect of norspermidine and
norspermine was not limited to B. subtilis. Both moleculesCell 149, 684–692, April 27, 2012 ª2012 Elsevier Inc. 689
Figure 6. Norspermidine Inhibits Biofilm Forma-
tion by S. aureus
(A) The effect of the numbered compounds displayed in
Figure 5A on the formation of submerged biofilms by
S. aureus strain SCO1. The compounds were tested at
500 mM. Biofilm formation was visualized by CV staining of
submerged biofilms.
(B) Quantification of the effects of norspermidine, nor-
spermine, spermine, and spermidine as measured by CV
staining (see Experimental Procedures). The results are an
average of three independent experiments done in tripli-
cate. The error bars indicate standard deviation. See also
Figure S6. D
inhibited the formation of submerged biofilms by S. aureus and
E. coli. Indeed, the same pattern of molecules that were active
or inactive in inhibiting biofilm formation by B. subtilis was
observed for S. aureus and E. coli. It is therefore attractive to
posit that the broad spectrum of norspermidine and norspermine
reflects a common mechanism of targeting the exopolysacchar-
ide. Indeed, this was supported by fluorescence microscopy
with S. aureus and E. coli and light scattering experiments with
A690 Cell 149, 684–692, April 27, 2012 ª2012 Elsevier Inc.
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TRpurified exopolysaccaride from E. coli.
However, we do not exclude the possibility
that norspermidine also targets DNA, which is,
of course, negatively charged and is known to
be a component of the matrix for certain
bacteria, such as S. aureus (Branda et al., 2005).
What is the nature of interaction of norspermi-
dine with exopolysaccharides? Exopolysac-
charides often contain negatively charged
residues (e.g., uronic acid) or neutral sugars
TE
with polar groups (e.g., poly-N-acetylglucosamine) (Kropec
et al., 2005; Sutherland, 2001). Molecular modeling suggests
that the amines in norspermidine, but not those in spermidine,
are capable of interacting with such charged (Figures 5C and
5D) or polar groups (Figure S7) in secondary structure of the
exopolysaccharide. We suggest that this interaction enhances
the ability of the polymers to interact with each other or with other
parts of the polymer chain. Indeed, the results of fluorescence
C
Figure 7. Norspermidine Inhibits Biofilm Forma-
tion by E. coli
(A) The effect of the numbered compounds shown in
Figure 5A on submerged biofilm formation by E. coli strain
MC4100. The compounds were tested at 500 mM. Biofilm
formation was visualized by CV staining of submerged
biofilms.
(B) shows quantification of the effects of norspermidine,
norspermine, spermine, and spermidine as measured by
CV staining (see Experimental Procedures). The results
are an average of three independent experiments done in
triplicate. The error bars indicate standard deviation. See
also Figure S6.
microscopy (Figure 3), dynamic light scattering (Figure 4A), and
scanning electron microscopy (Figure 4B) appear to indicate
that the exopolysaccharide network collapses upon addition of
norspermidine. We speculate that exopolysaccharide polymers
form an interwoven meshwork in the matrix that helps hold cells
together and that condensation of the polymers in response to
norspermidine weakens the meshwork and causes release of
polymers.
Given the apparent versatility of norspermidine and norsper-
mine in inhibiting biofilm formation by a variety of bacteria, it is
conceivable that these and other, tailor-made polyamines that
bind with high affinity to specific exopolysaccharides might
offer a general approach (in conjunction with D-amino acids)
to preventing biofilm formation by medically and industrially
important microorganisms. Indeed, in preliminary experiments
we have succeeded in synthesizing polyamine-like molecules
with enhanced potency in blocking biofilm formation by
S. aureus that were designed on the basis of model building
for optimal interaction with poly N-acetyl glucosamine (data
not shown).EXPERIMENTAL PROCEDURES
Colony and Pellicle Formation
For pellicle formation in liquid medium, cells were grown to exponential phase,
and 3 ml of culture were mixed with 3 ml of medium in a 12-well plate (VWR).
Plates were incubated at 23C for 3 days. Images of the pellicles were
recorded similarly. ASubmerged Biofilm FormationFor S. aureus, cells were grown in Luria-Bertani (LB) overnight and then diluted
1:1,000 in Tryptic Soy Broth (Sigma), applied with 3%NaCl and 0.5% glucose.
Plates were incubated at 37C for 24 hr. For E. coli, cells were grown in LB
overnight, then diluted 1:100 in M9 and applied with 0.02% Casamino acid
solution and 0.5% glycerol. Plates were incubated in 30C for 3 days.R
Preparing Conditioned Medium
B. subtilis 3610 or its derivatives were grown in LB medium to exponential
phase. A total of 1 ml of culture was then applied to 100 ml of MSgg medium
and grown in a 500 liter flask at 22C. Next, pellicles and conditioned medium
were collected by centrifugation at 8,000 rpm for 15 min. The conditioned
medium (supernatant fluid) was removed and filtered through a 0.22 mm filter.
The filtrates were stored at 4C. For further purification the biofilm-inhibiting
material was fractionated on a C-18 Sep Pak cartridge with a stepwise elution
of 0% to 60% methanol with steps of 5%.ET
Separation, Identification, and Quantification of Norspermidine
See Supplemental Information for details.Fluorescence Microscopy
Fluorescence microscopy was carried out with 3-day-old pellicles. For
TasA-mcherry detection, cells were washed with PBS buffer and suspended
in 50 ml of PBS buffer. For exopolysaccharide detection, pellicles were
collected and washed with PBS. The cells were labeled by replacing the
PBS with Texas red-concanavalin A (50 mM) and incubating with shaking in
room temperature for an hour. The cells were rinsed again with PBS, placed
on poly-L-lysine (Sigma) pretreated slides and then imaged with an Olympus
workstation. Cells were imaged with various exposure times and images
were taken under conditions in which concanavalin A staining was largely
specific to exopolysaccharide (see Figure S3). Images were taken with an
automated software program, SimplePCI.
RCrystal Violet Staining
Crystal Violet (CV) staining was done as described previously except that the
cells were grown in 12-well plates (O’Toole and Kolter, 1998). Wells were
stained with 500 ml of 1.0% CV dye, rinsed twice with 2 ml doubly distilled
water (DDW), and thoroughly dried. For quantification, 1 ml of 95% ethanol
was added to each well. Plates were incubated for 1 hr at room temperature
with shaking. CV solution was diluted and the optical density (OD) at 595 nm
was measured with Ultraspec 2000 (Pharmacia Biotech).
Exopolysaccharide Purification
Pellicles were harvested in day 3, washed twice in PBS, and mildly sonicated.
Cells were removed by centrifugation. The supernatant fluid was mixed with
cold isopropanol in a 5:1 ratio and incubated at 4C overnight. Samples
were centrifuged at 8,000 rpm, 4C, for 10 min. Pellets were resuspended
in a digestion mix of 0.1 M MgCl2, 0.1 mg/ml DNase, and 0.1 mg/ml RNase
solution, mildly sonicated, and incubated for 4 hr at 37C. Samples were
extracted twice with phenol-chloroform. The aquatic fraction was dialyzed
for 48 hr with Slide-A-Lyzer Dialysis cassettes by Thermo Fisher, 3,500
MCWO. Samples were lyophilized.
Dynamic Light Scattering
See Supplemental Information for details.
Scanning Electron Microscopy
Exopolysaccharide was dissolved in DDW at a final concentration of 10 mg/ml
and mixed with norspermidine or spermidine (0.75 mM final concentration).
Samples were then spotted onto poly-L-lysine-coated Si surfaces and kept
in a humid environment for 30 min. The Si pieces were then rinsed with
DDW. To capture the native, hydrated, state of exopolysaccharide, we crit-
ical-point dried the samples. Images were obtained with a Zeiss Supra55 Field
Emission scanning electron microscope. For further details see Extended
Experimental Procedures.
Primers
See Table S1.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two table and can be found with this article online at
doi:10.1016/j.cell.2012.02.055.
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